Product Code: ETC355764 | Publication Date: Aug 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India intraocular lens market import shipment demonstrated robust growth with a CAGR of 24.1% from 2020 to 2024. However, there was a slight decline in growth rate of -7.0% between 2023 and 2024. Despite the dip in growth, the market maintained an upward trajectory, indicating overall expansion with some stabilization towards the end of the period.
The India intraocular lens market is estimated to be valued at $215 million in 2025, and is expected to grow at a CAGR of 8.3%. The major drivers for this growth are rising prevalence of eye disorders, increasing awareness about eye diseases, government initiatives for better healthcare facilities, and increasing geriatric population. Moreover, the launch of advanced IOLs such as presbyopia correction lenses (PCIOLs), accommodative IOLs (AIOLS), multifocal IOLs (MFIOLS) has further fuelled the market growth in India.
The India Intraocular Lens (IOL) Market is driven by several factors that contribute to its growth and adoption in the ophthalmology field. One of the key drivers is the increasing prevalence of cataracts and age-related vision disorders in the aging population. As the geriatric population grows, the demand for cataract surgeries and IOLs also increases. IOLs are essential in cataract surgery to replace the clouded natural lenses, restoring clear vision and improving quality of life for patients. Additionally, advancements in medical technology and surgical techniques have led to the development of innovative IOLs with enhanced optical properties and reduced post-operative complications. These advancements drive the adoption of premium IOLs, including multifocal and toric IOLs, for achieving better visual outcomes. Moreover, the growing awareness about the benefits of refractive lens exchange (RLE) procedures and the trend towards corrective eye surgeries for presbyopia further contribute to the market`s growth. As healthcare infrastructure improves and access to eye care services expands, the India Intraocular Lens Market is expected to witness sustained growth.
The India Intraocular Lens (IOL) Market faces several challenges that impact its widespread adoption and use in eye care procedures. One of the key challenges is the high cost of premium IOLs, such as multifocal and toric lenses, which may limit their accessibility for some patients. Ensuring affordability and accessibility of advanced IOLs is essential for providing comprehensive eye care solutions to a broader population. Additionally, the lack of awareness and education about eye health and available treatment options can result in delayed or inadequate interventions for vision disorders. Raising awareness about the benefits of IOLs and the importance of regular eye check-ups is crucial for early diagnosis and timely treatment. Moreover, the availability of skilled eye care professionals and adequate healthcare infrastructure in rural and remote areas can be a challenge, impacting access to advanced eye care services, including cataract surgeries and IOL implantations. Ensuring equitable access to eye care facilities is essential for addressing these disparities and providing quality eye care to all segments of the population. Furthermore, the COVID-19 pandemic has disrupted elective surgeries and affected patient visits to healthcare facilities, leading to a temporary decline in IOL procedures. As the healthcare system adapts to the post-pandemic scenario and enhances eye care services, it will overcome these challenges and witness growth in the India Intraocular Lens Market.
The India Intraocular Lens (IOL) Market experienced significant disruption and challenges during the COVID-19 pandemic. The outbreak of the virus led to nationwide lockdowns and restrictions, which resulted in the postponement of non-urgent medical procedures, including elective cataract surgeries. As a result, the demand for intraocular lenses declined during the initial phases of the pandemic. The temporary closure of eye care clinics and hospitals, coupled with the fear of contracting the virus in healthcare settings, also led to reduced patient visits and consultations for cataract and other eye-related treatments. This further impacted the adoption of intraocular lenses in the country. Moreover, the disruptions in global supply chains and manufacturing operations during the pandemic affected the availability of IOLs and their raw materials. This led to temporary shortages and delays in the procurement of IOLs, causing challenges in meeting the demand for cataract surgeries and other vision correction procedures. However, as the healthcare system adapted to the new normal and implemented safety protocols, eye care facilities gradually resumed their operations. The increasing focus on telemedicine and virtual consultations also helped to address the concerns of patients and allowed for the provision of remote eye care services. Furthermore, the COVID-19 pandemic accelerated the adoption of advanced technologies in the eye care industry. Innovations in digital health and remote monitoring have facilitated better patient care and post-operative follow-ups for individuals who have undergone cataract surgeries with IOL implants.
The India Intraocular Lens (IOL) Market is characterized by the presence of several key players that contribute significantly to the industry`s growth and innovation. Some of the prominent companies operating in this market include Alcon Laboratories (India) Pvt. Ltd., Carl Zeiss India Pvt. Ltd., Bausch & Lomb India Pvt. Ltd., Johnson & Johnson Private Limited, and Aurolab.